Mitsiades CS - Search Results

1

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.

Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, Dastur A, Amzallag A, Ramaswamy S, Tesar B, Jenkins CE, Hannett NM, McMillin D, Sanda T, Sim T, Kim ND, Look T, Mitsiades CS, Weng AP, Brown JR, Benes CH, Marto JA, Young RA, Gray NS. Kwiatkowski N, et al. Among authors: mitsiades cs. Nature. 2014 Jul 31;511(7511):616-20. doi: 10.1038/nature13393. Epub 2014 Jun 22. Nature. 2014. PMID: 25043025 Free PMC article.

2

Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N. Mitsiades CS, et al. Among authors: mitsiades n. J Clin Endocrinol Metab. 2006 Oct;91(10):4013-21. doi: 10.1210/jc.2005-2472. Epub 2006 Jul 18. J Clin Endocrinol Metab. 2006. PMID: 16849420

3

Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.

Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N. Mitsiades CS, et al. Among authors: mitsiades n. Mol Cancer Ther. 2007 Mar;6(3):1070-8. doi: 10.1158/1535-7163.MCT-06-0449. Mol Cancer Ther. 2007. PMID: 17363500

4

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.

Weisberg E, Kung AL, Wright RD, Moreno D, Catley L, Ray A, Zawel L, Tran M, Cools J, Gilliland G, Mitsiades C, McMillin DW, Jiang J, Hall-Meyers E, Griffin JD. Weisberg E, et al. Mol Cancer Ther. 2007 Jul;6(7):1951-61. doi: 10.1158/1535-7163.MCT-06-0810. Mol Cancer Ther. 2007. PMID: 17620426

5

Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.

Mitsiades CS, Hayden P, Kotoula V, McMillin DW, McMullan C, Negri J, Delmore JE, Poulaki V, Mitsiades N. Mitsiades CS, et al. Among authors: mitsiades n. J Clin Endocrinol Metab. 2007 Dec;92(12):4845-52. doi: 10.1210/jc.2007-0942. Epub 2007 Sep 11. J Clin Endocrinol Metab. 2007. PMID: 17848408

6

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.

Poulaki V, Mitsiades CS, Kotoula V, Negri J, McMillin D, Miller JW, Mitsiades N. Poulaki V, et al. Among authors: mitsiades n, mitsiades cs. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4706-19. doi: 10.1167/iovs.06-1147. Invest Ophthalmol Vis Sci. 2007. PMID: 17898295

7

The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies.

Mitsiades CS, McMillin DW, Klippel S, Hideshima T, Chauhan D, Richardson PG, Munshi NC, Anderson KC. Mitsiades CS, et al. Hematol Oncol Clin North Am. 2007 Dec;21(6):1007-34, vii-viii. doi: 10.1016/j.hoc.2007.08.007. Hematol Oncol Clin North Am. 2007. PMID: 17996586 Review.

8

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.

Weisberg E, Wright RD, McMillin DW, Mitsiades C, Ray A, Barrett R, Adamia S, Stone R, Galinsky I, Kung AL, Griffin JD. Weisberg E, et al. Mol Cancer Ther. 2008 May;7(5):1121-9. doi: 10.1158/1535-7163.MCT-07-2331. Epub 2008 Apr 29. Mol Cancer Ther. 2008. PMID: 18445657 Free PMC article.

9

Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib.

Mitsiades CS, Hideshima T, Chauhan D, McMillin DW, Klippel S, Laubach JP, Munshi NC, Anderson KC, Richardson PG. Mitsiades CS, et al. Semin Hematol. 2009 Apr;46(2):166-75. doi: 10.1053/j.seminhematol.2009.02.003. Semin Hematol. 2009. PMID: 19389500 Free PMC article. Review.

10

Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.

McMillin DW, Ooi M, Delmore J, Negri J, Hayden P, Mitsiades N, Jakubikova J, Maira SM, Garcia-Echeverria C, Schlossman R, Munshi NC, Richardson PG, Anderson KC, Mitsiades CS. McMillin DW, et al. Among authors: mitsiades n, mitsiades cs. Cancer Res. 2009 Jul 15;69(14):5835-42. doi: 10.1158/0008-5472.CAN-08-4285. Epub 2009 Jul 7. Cancer Res. 2009. PMID: 19584292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page